Chengzhi Huang

772 total citations
38 papers, 475 citations indexed

About

Chengzhi Huang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Chengzhi Huang has authored 38 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Chengzhi Huang's work include Colorectal and Anal Carcinomas (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and MicroRNA in disease regulation (6 papers). Chengzhi Huang is often cited by papers focused on Colorectal and Anal Carcinomas (7 papers), Colorectal Cancer Surgical Treatments (6 papers) and MicroRNA in disease regulation (6 papers). Chengzhi Huang collaborates with scholars based in China. Chengzhi Huang's co-authors include Xueqing Yao, Junjiang Wang, Xueqing Yao, Yue Zhou, Weixian Hu, Xiaoyan Zhao, Duoduo Zhang, Zhubo Li, Jie Zhang and Yong Li and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Biomaterials.

In The Last Decade

Chengzhi Huang

33 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengzhi Huang China 13 218 144 128 97 74 38 475
Quanli Han China 13 192 0.9× 130 0.9× 175 1.4× 90 0.9× 47 0.6× 33 411
Qiaonan Shan China 12 305 1.4× 101 0.7× 173 1.4× 63 0.6× 73 1.0× 16 547
Jianzhuang Ren China 12 180 0.8× 102 0.7× 82 0.6× 88 0.9× 47 0.6× 26 401
Xipeng Zhang China 14 293 1.3× 213 1.5× 160 1.3× 70 0.7× 36 0.5× 38 572
Zhaowei Zou China 11 283 1.3× 148 1.0× 78 0.6× 72 0.7× 50 0.7× 20 454
Zunqi Hu China 12 294 1.3× 154 1.1× 73 0.6× 53 0.5× 54 0.7× 27 495
Feifei Yan China 12 122 0.6× 53 0.4× 135 1.1× 132 1.4× 80 1.1× 28 496
Yeon‐Mi Ryu South Korea 14 238 1.1× 67 0.5× 190 1.5× 82 0.8× 69 0.9× 29 602
Fatemeh Rezaei‐Tazangi Iran 12 277 1.3× 129 0.9× 121 0.9× 69 0.7× 40 0.5× 55 572
Chloé Sauzay France 12 329 1.5× 204 1.4× 150 1.2× 160 1.6× 62 0.8× 19 671

Countries citing papers authored by Chengzhi Huang

Since Specialization
Citations

This map shows the geographic impact of Chengzhi Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengzhi Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengzhi Huang more than expected).

Fields of papers citing papers by Chengzhi Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengzhi Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengzhi Huang. The network helps show where Chengzhi Huang may publish in the future.

Co-authorship network of co-authors of Chengzhi Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengzhi Huang. A scholar is included among the top collaborators of Chengzhi Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengzhi Huang. Chengzhi Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Linfeng, Jinghui Li, Guosheng Zhang, et al.. (2025). Efficacy and safety of fruquintinib combined with PD-1 inhibitors in the treatment of refractory metastatic colorectal cancer: a systematic review and meta-analysis. Expert Review of Anticancer Therapy. 25(4). 411–421.
3.
Liu, Zhiyuan, Kaihong Huang, Jiawei Wu, et al.. (2025). Artificial intelligence-based model to predict recurrence after local excision in T1 rectal cancer. European Journal of Surgical Oncology. 51(6). 109717–109717. 4 indexed citations
4.
Li, Jinghui, Linfeng Liu, Jiawei Wu, et al.. (2025). Prognostic and clinicopathological significance of C-reactive protein–albumin–lymphocyte(CALLY) in patients with digestive system neoplasms: a systematic review and meta-analysis. World Journal of Surgical Oncology. 23(1). 114–114. 4 indexed citations
5.
Liu, Lin, et al.. (2025). One-Step Solvothermal Synthesis of Carbon Dots for Rapid and Accurate Determination of Hemin Content. Molecules. 30(6). 1343–1343. 1 indexed citations
6.
7.
Li, Yunlong, Zhiyuan Liu, Ping Wang, et al.. (2024). Bioengineered Extracellular Vesicles Delivering siMDM2 Sensitize Oxaliplatin Therapy Efficacy in Colorectal Cancer. Advanced Healthcare Materials. 14(6). e2403531–e2403531.
8.
Huang, Chengzhi, Kege Yang, Jiajia Li, et al.. (2024). Extracellular vesicle‐packaged lncRNA from cancer‐associated fibroblasts promotes immune evasion by downregulating HLA‐A in pancreatic cancer. Journal of Extracellular Vesicles. 13(7). 25 indexed citations
9.
Huang, Chengzhi, et al.. (2024). CPE correlates with poor prognosis in gastric cancer by promoting tumourigenesis. Heliyon. 10(9). e29901–e29901. 1 indexed citations
10.
Zhang, Yuqing, Yiyi Zhang, Jinhai Deng, et al.. (2024). Non-volatile double-tunable vortex metalens design based on Sb2S3 using deep neural network and particle swarm optimization algorithm. Optics Communications. 560. 130453–130453. 2 indexed citations
11.
Guan, Ruo‐Yu, Jiawei Wu, Zheng Yuan, et al.. (2024). Poorly controlled type II diabetes mellitus significantly enhances postoperative chemoresistance in patients with stage III colon cancer. World Journal of Gastroenterology. 31(3). 98688–98688. 1 indexed citations
12.
13.
Huang, Chengzhi, Yue Zhou, Qi‐Song Tong, et al.. (2022). Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer. Biomaterials. 290. 121827–121827. 23 indexed citations
14.
Zhang, Qing, et al.. (2022). Low-dose orlistat promotes the therapeutic effect of oxaliplatin in colorectal cancer. Biomedicine & Pharmacotherapy. 153. 113426–113426. 24 indexed citations
15.
Huang, Chengzhi, Yuwen Luo, Xin Chen, et al.. (2021). A Correlation Study of Prognostic Risk Prediction for Colorectal Cancer Based on Autophagy Signature Genes. Frontiers in Oncology. 11. 595099–595099. 9 indexed citations
16.
Luo, Yuwen, Deqing Wu, Junjiang Wang, et al.. (2021). Long-term oncological outcomes of low anterior resection for rectal cancer with and without preservation of the left colic artery: a retrospective cohort study. BMC Cancer. 21(1). 171–171. 12 indexed citations
17.
Huang, Chengzhi, Minjia Wang, Junjiang Wang, et al.. (2020). Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer. Biochemical Pharmacology. 189. 114390–114390. 17 indexed citations
18.
Huang, Chengzhi, et al.. (2019). Antihistamine effects and safety of fexofenadine: a systematic review and Meta-analysis of randomized controlled trials. BMC Pharmacology and Toxicology. 20(1). 72–72. 23 indexed citations
19.
Huang, Chengzhi, et al.. (2018). MicroRNA-17 and the prognosis of human carcinomas: a systematic review and meta-analysis. BMJ Open. 8(5). e018070–e018070. 16 indexed citations
20.
Huang, Chengzhi, et al.. (2018). Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations. Chinese Medical Journal. 131(10). 1232–1239. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quanli Han Breakdown of academic impact, for papers by Qiaonan Shan Breakdown of academic impact, for papers by Jianzhuang Ren Breakdown of academic impact, for papers by Xipeng Zhang Breakdown of academic impact, for papers by Zhaowei Zou Breakdown of academic impact, for papers by Zunqi Hu Breakdown of academic impact, for papers by Feifei Yan Breakdown of academic impact, for papers by Yeon‐Mi Ryu Breakdown of academic impact, for papers by Fatemeh Rezaei‐Tazangi Breakdown of academic impact, for papers by Chloé Sauzay
Rankless by CCL
2026